January 29, 2019

U-M Urologists contribute to Renal and Urology News article

Drs. Jeff Tosoian and Arvin George contributed an accompanying editorial for an article on active surveillance of prostate cancer

The article examined whether active surveillance is a viable option for select men younger than 60 years who have low-volume, low-risk prostate cancer.

"In a retrospective study, Adam S. Feldman, MD, of Massachusetts General Hospital in  Boston, and colleagues compared 417 men who began AS when they were younger than 60 years with 1667 who began AS at age 60 years or older. At a median follow-up of 6.2 years, the investigators found no significant difference in 5-year rates of biopsy progression-free survival in the younger and older men (83% in both), treatment-free survival (74% vs 71%), metastasis-free survival (99.7% vs 99%), or PCa-specific survival (100% vs 99.7%), Dr Feldman's team reported in The Journal of Urology."

Click here to read the full article.